Transthyretin Amyloid Cardiomyopathy Treatment Market is estimated to be valued at US$ 1.69 Bn in 2023, and is expected to exhibit a CAGR of 31.1% by 2030. Mr. Shah Coherent Market Insights Pvt. Ltd.
Novel Modes of Treatment and Drugs Spur the Demand in the Immuno-oncology Market: Fact Report ROCKVILLE, MD, UNITED STATES, March 13, ...
All the latest breaking news on Credit Suisse. Browse ibtimes archives of photos, videos and articles on Credit Suisse.
19h
NEW YORK, NY / ACCESS Newswire / March 12, 2025 / If you suffered a loss on your GSK plc (NYSE:GSK) investment and want to learn about a ...
GSK’s ViiV Healthcare has shared clinical data on three potential long-acting HIV treatments, providing a look at how its ...
Gilead plans to go straight to Phase III studies for once-yearly lenacapavir, while GSK and Viiv will push forward with their ...
After a year of controversy and complaints, Sen. Elizabeth Warren is asking a federal watchdog to investigate GSK over its ...
In a key development for Pakistan’s pharmaceutical sector, Haleon Pakistan Limited, formerly known as GlaxoSmithKline ...
Cancer Gene Therapy Market to Soar to US$ 17.57 Billion by 2033, Registering a Robust CAGR of 18.24%
The global Cancer Gene Therapy Market was valued at US$ 3.89 billion in 2024 and is projected to experience a remarkable surge to US$ 17.57 billion by 2033, growing at a compelling CAGR of 18.24% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback